دورية أكاديمية

Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.

التفاصيل البيبلوغرافية
العنوان: Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.
المؤلفون: Carnes NA; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Asher AK; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Bohm MK; Division of Unintentional Injury, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Bessler PA; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
المصدر: Substance use & misuse [Subst Use Misuse] 2021; Vol. 56 (13), pp. 1933-1940. Date of Electronic Publication: 2021 Aug 06.
نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.
اللغة: English
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9602153 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2491 (Electronic) Linking ISSN: 10826084 NLM ISO Abbreviation: Subst Use Misuse Subsets: MEDLINE
أسماء مطبوعة: Publication: London : Informa Healthcare
Original Publication: Monticello, NY : Dekker, 1996-
مواضيع طبية MeSH: HIV Infections*/prevention & control , Hepatitis C*/prevention & control , Substance Abuse, Intravenous*, Humans ; Needle-Exchange Programs ; Syringes ; United States
مستخلص: Background: Syringe service programs (SSP) increasingly serve rural areas of the United States, yet little is known about access and perceived need for their services. Objectives : This paper presents the HIV and viral hepatitis prevention, testing, and treatment, and, substance use disorder treatment and overdose prevention services offered at three SSPs and which services their clients accessed. Across the three SSPs, 45 clients (people who inject drugs [PWID]), 11 staff, and five stakeholders were interviewed. Results : Most clients ( n  = 34) reported accessing SSP services weekly and primarily for sterile syringes and injection-related supplies. All clients reported testing for HIV at least once, though concern for acquiring or transmitting HIV was divided between some or no concern. Most clients ( n  = 43) reported testing for hepatitis C virus (HCV). Concern for acquiring or transmitting HCV was also mixed. Vaccination for hepatitis A and/or B teetered around half (HAV: n  = 23) to a third (HBV: n  = 15). Most clients ( n  = 43) knew where to access the overdose countering medication, Narcan. Feelings about substance use treatment options varied, yet most felt not enough were available. Of note, not all assessed services were offered by the sampled SSPs. Conclusions/Importance : The findings help us understand PWIDs' rationale regarding services accessed and preference for particular services. The need for some services was not perceived by those at risk for the illness the services addressed. Discussing risk and providing tailored education is important when providing SSP services to rural residing PWIDs.
References: Subst Use Misuse. 2020;55(14):2268-2277. (PMID: 32748730)
Health Promot Pract. 2018 Mar;19(2):170-174. (PMID: 29363333)
SSM Popul Health. 2018 Aug 31;6:72-74. (PMID: 30225336)
MMWR Morb Mortal Wkly Rep. 2018 May 11;67(18):529-532. (PMID: 29746453)
MMWR Morb Mortal Wkly Rep. 2016 Dec 02;65(47):1336-1342. (PMID: 27906906)
MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427. (PMID: 30605448)
J Urban Health. 2017 Aug;94(4):572-586. (PMID: 28639058)
Am J Epidemiol. 2019 Aug 1;188(8):1539-1551. (PMID: 31150044)
MMWR Morb Mortal Wkly Rep. 2019 Mar 15;68(10):253-254. (PMID: 30870405)
JAMA. 2016 Apr 26;315(16):1750-66. (PMID: 27063997)
J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):323-331. (PMID: 27763996)
JAMA. 2018 Apr 3;319(13):1312-1313. (PMID: 29614168)
MMWR Surveill Summ. 2017 Jan 13;66(2):1-7. (PMID: 28081057)
Am J Public Health. 2020 Apr;110(4):517-519. (PMID: 32078343)
J Infect Dis. 2020 Sep 2;222(Suppl 5):S239-S249. (PMID: 32877545)
J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):373-382. (PMID: 29271829)
N Engl J Med. 2016 Jul 21;375(3):229-39. (PMID: 27468059)
JAMA Psychiatry. 2014 Jul 1;71(7):821-6. (PMID: 24871348)
MMWR Morb Mortal Wkly Rep. 2020 Apr 24;69(16):499-500. (PMID: 32324723)
معلومات مُعتمدة: CC999999 United States ImCDC Intramural CDC HHS
فهرسة مساهمة: Keywords: HIV; Syringe service programs (SSPs); overdose prevention; services provision; substance use disorder; viral hepatitis
تواريخ الأحداث: Date Created: 20210806 Date Completed: 20211020 Latest Revision: 20230919
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10506068
DOI: 10.1080/10826084.2021.1958863
PMID: 34353216
قاعدة البيانات: MEDLINE
الوصف
تدمد:1532-2491
DOI:10.1080/10826084.2021.1958863